Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed related topic links 'Melanoma' and 'MedlinePlus Genetics' from the page's related topics section.
    Difference
    0.1%
    Check dated 2026-04-10T08:54:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the study page.
    Difference
    0.1%
    Check dated 2026-04-03T05:29:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed the melanoma keyword tag and the related topics MedlinePlus Genetics from the study page’s terms.
    Difference
    0.1%
    Check dated 2026-03-27T01:31:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous v3.4.3 label has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T21:08:43.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Melanoma is now listed as a related topic, and MedlinePlus Genetics is added to related topics. The site revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-12T18:48:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Melanoma topic tag and the related MedlinePlus Genetics topics have been removed from the page. This reduces disease-specific context and topic mapping for search and classification.
    Difference
    0.1%
    Check dated 2026-02-19T04:54:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.